![](https://www.diabetesnews.com/wp-content/uploads/2012/09/Expiry-drugs1-150x150.jpg)
FORXIGA is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments.
Read more